Global leaders in patient advocacy assembled during the 2024 World Conference on Lung Cancer to shed light on ongoing initiatives. Read more
Dr. Yixian Crystal Chen recently presented results that demonstrate fine particulate matter poses health risks, even for those with no smoking history. Read more
Dr. Benjamin Besse recently discussed detailed findings from the now discontinued CARMEN-LC03 trial. Read more
Dr. Hidehito Horinouchi said treatment with Teliso-V demonstrated promising and durable responses in Asian cohort, particularly those with high c-Met expression. Read more
Dr. Jacob Sands presented findings that show a progression-free survival advantage for Dato-DXd versus docetaxel in the non-squamous cohort. Read more
US FDA approves TTFields therapy as a treatment for mNSCLC. Read more
Dr. Leticia Nogueira and other experts explored non-tobacco factors that are playing a role in our evolving knowledge during a WCLC 24 plenary session. Read more
Dr. Kenneth O’Byrne says research shows novel method for analyzing tissue samples may help predict immunotherapy response. Read more
Dr. Charles Rudin says early data look promising for I-DXd in patients with ES-SCLC. Read more
Drs. Ramaswamy Govindan, Richard Haspel, and Aparna Sharma took the audience on a guided tour of pragmatic lung cancer genomics. Read more